David Barros

Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis

Lluís Ballell, Robert H. Bates, Rob J. Young et al. · ChemMedChem · 2013 · 310 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

Katherine A. Abrahams, Jonathan A. G. Cox, Vickey L. Spivey et al. · PLoS ONE · 2012 · 178 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of a Potent and Specific <i>M. tuberculosis</i> Leucyl-tRNA Synthetase Inhibitor: (<i>S</i>)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol (GSK656)

Xianfeng Li, Vincent Hernandez, Fernando Rock et al. · Journal of Medicinal Chemistry · 2017 · 162 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity

Angus Cameron, Jon Read, R. Tranter et al. · Journal of Biological Chemistry · 2004 · 145 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

Modesto J. Remuiñán, Esther Pérez‐Herrán, Joaquín Rullás et al. · PLoS ONE · 2013 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15